Loading...
Novel Lysyl Oxidase Inhibitors Attenuate Hallmarks of Primary Myelofibrosis in Mice
Primary myelofibrosis (PMF) is a chronic myeloproliferative neoplasm (MPN) that usually portends a poor prognosis with limited therapeutic options available. Currently only allogeneic stem cell transplantation is curative in those who are candidates, while administration of the JAK1/2 inhibitor ruxo...
Saved in:
| Published in: | Int J Hematol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7503219/ https://ncbi.nlm.nih.gov/pubmed/31637674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12185-019-02751-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|